U.S. FDA clears Pfizer COVID-19 booster for older and at-risk Americans

13 Sept 11:09 Key points summarised by AI

The U.S. FDA authorized a booster dose of the Pfizer-BioNTech COVID-19 vaccine for specific populations.
Eligibility includes individuals aged 65 and older, people at high risk of severe disease, and those regularly exposed to the virus, such as healthcare workers.
This decision paves the way for a swift rollout of booster shots for millions who received their second dose at least six months ago.
The FDA's authorization is broader than an advisory panel's recommendation but focuses on vulnerable groups, with the CDC expected to issue official implementation guidance.

Sihasak urges Thais in Europe to stay alert as protests spread

Yesterday 12:06 Key points summarised by AI

Thai Foreign Minister Sihasak Phuangketkeow advises Thai nationals in Europe to avoid protest areas and reconsider non-essential travel, citing widespread unrest in countries like France, Italy, and Spain.
The warning comes as demonstrations escalate, with some turning violent, prompting concerns for safety and leading to an emergency Cabinet meeting in Italy and a proposed postponement of diplomatic talks.
Thai embassies and the Department of Consular Affairs issue advisories, urging citizens to monitor local developments, follow official announcements, and register their travel details for assistance, while emphasizing that no Thais have been directly affected yet.